Breaking News on Global Pharmaceutical Technology & Manufacturing

Drug Delivery: Top Headlines

CeQur's $100m financing to scale-up insulin delivery patch-pump production

CeQur's PaQ delivery patch-pump is set to be launched next year

03-Sep-2015 - GLP-1 drugs and oral formulations will not diminish demand for insulin patch-pumps says CeQur, which has raised $100m (€89m) to support production of its PaQ delivery device.

Related news

News in brief

Sanofi seeks to expand UK inhalables site with an eye on CMO business

03-Sep-2015 - Sanofi wants to expand its inhalable drug production site in Cheshire, UK to increase capacity for both its own brand drug production operations and its contract manufacturing business.

BMS pays $125m to Promedior in second 'right-to-buy' option in fibrosis space

01-Sep-2015 - Bristol-Myers Squibb has acquired the rights to buy immunotherapy firm Promedior and could pay up to $1.25bn (€1.1bn) depending on the clinical development of its lead fibrosis product PRM-151.

Scientists build ‘microfish’ robots for controlled drug delivery

27-Aug-2015 - US researchers say 3-D printed microscopic fish robots will allow intelligent drug delivery.

Novo Nordisk to pump $2bn into diabetes network on back of oral GLP-1 milestone

27-Aug-2015 - Novo Nordisk could spend up to $2bn (€1.8bn) on two facilities to support its diabetes portfolio, including an oral long-acting GLP-1 analogue set to enter Phase III trials.

Device advice: Intertek study shows its key to consider devices in formulation development

26-Aug-2015 - Pharma firms developing inhalable drugs often fail to test that their formulations are compatible with their intended delivery devices early enough according to Intertek.

Google launches life sci unit as standalone Alphabet company

24-Aug-2015 - Google has announced plans to launch its life sciences team as a standalone unit under its new Alphabet structure.

Unilife whistleblower case blows over; Ex-exec apologises

20-Aug-2015 - An erstwhile whistleblower who accused Unilife of fraud and violating US FDA validation regulations has apologised and withdrawn his allegations.

Drug Delivery: Featured news

Key Industry Events


Access all events listing

Our events, Shows & Conferences...